Lifesciences@Work : We help scientists build their business

Lanthio Pharma

Lanthio Pharma is a Dutch botechnology company, focused on developing lanthipeptides as innovative drugs for medical conditions that represent high medical needs. The company uses its proprietary technology to discover these lanthipeptides, which have characteristics that make them more suitable as drugs compared to natural peptides.

One lanthipeptide has already been out-licensed and several others are in earlier development and discovery stages for important medical indications like fibrosis and cadiovascular diseases. Lanthio Pharma has signed a technology alliance with German based MorphoSys, which has acquired the rights to commercialise Lanthio Pharma’s technology via drug discovery service deals.